Viewing Study NCT03321318


Ignite Creation Date: 2025-12-25 @ 5:04 AM
Ignite Modification Date: 2026-02-28 @ 7:10 PM
Study NCT ID: NCT03321318
Status: UNKNOWN
Last Update Posted: 2017-10-25
First Post: 2017-07-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: AK-R215 Pharmacokinetic Study Phase I
Sponsor: Alvogen Korea
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: AK-CTR-215-I-02
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators